Product category:
Materials Testing
News Release from: Thermo Fisher Scientific (Informatics) | Subject: Galileo LIMS
Edited by the Manufacturingtalk Editorial
Team on 24 May 2006
Greater flexibility from LIMS
Thermo Electron has announced enhancements to its Galileo LIMS, providing greater flexibility for high throughput ADMET experiments that facilitate lead optimization in drug discovery.
Thermo Electron has announced enhancements to its Galileo LIMS, providing greater flexibility for high throughput ADMET experiments that facilitate lead optimization in drug discovery Galileo is a LIMS designed specifically to support in vitro ADMET experiments, allowing users to design, calculate and report data from metabolic stability, drug-drug interaction, protein binding, permeability and enzyme kinetics studies
This article was originally published on Manufacturingtalk on 12 Oct 2005 at 8.00am (UK)
Related stories
LIMS for ADME/Tox experiments
Thermo Electron has announced Galileo LIMS v 3.1, providing additional functionality to increase efficiency in the demanding high-throughput environment of in vitro ADME/Tox discovery laboratories.
Bioequivalence solutions for pharmaceuticals
Thermo Fisher Scientific has announced a partnership with Megaware to deliver bioanalysis/equivalence solutions to pharmaceutical and contract research organisations.
LIMS plate handling capabilities
Thermo Fisher Scientific has produced a technical poster to highlight the plate handling capabilities of its Nautilus LIMS for high throughput applications.
Version 3.2 now gives users greater control over the assays performed with user-definable study types and customizable calculations.
"Galileo 3.2 expands in vitro research capabilities by enabling the full range of ADMET assays via user-definable calculations," said Dave Champagne, vice president and general manager of Thermo's informatics business.
"We continue to enhance Galileo with off-the-shelf functionality that users need to keep the study design flexible, while providing the benefits of a more standard approach to assay management, analysis, storage and reporting of the data." In addition to user-definable study types to increase flexibility, Galileo now offers user-configurable decision trees that allow the user to define scenarios under which flagged results require further review.
Questionable data is quickly reviewed with a new ability to filter data sets and to flag data based on comments entered during analytical data review.
Templating of design and output parameters, as well as result flagging, eliminates manual actions, saving time and reducing errors for users.
Galileo LIMS is offered as an alternative to manual calculations using spreadsheets, resulting in disparate files maintained in many locations in multiple file formats.
The LIMS enables drug discovery researchers to conduct high throughput in vitro screening and profiling of compounds to determine at an earlier and less costly stage which compounds might develop into commercially viable therapeutic drugs.
Galileo enhances the value of its acquired data by ensuring consistency of the ADME calculations and uploading to a corporate database for broad dissemination and use. Request a free brochure from Thermo Fisher Scientific (Informatics) ...
• Thermo Fisher Scientific (Informatics): contact details and other news
• Email this article to a colleague
• Register for the free Manufacturingtalk email newsletter
• Manufacturingtalk Home Page
Search the Pro-Talk network of sites
